Business Description
Carna Biosciences Inc
ISIN : JP3220550002
Total Employee Number:
74Description
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.67 | |||||
Equity-to-Asset | -0.07 | |||||
Debt-to-Equity | -13.45 | |||||
Debt-to-EBITDA | -2.09 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 0.63 | |||||
Beneish M-Score | -3.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -33.2 | |||||
3-Year EBITDA Growth Rate | -6.2 | |||||
3-Year EPS without NRI Growth Rate | -5.2 | |||||
3-Year FCF Growth Rate | -22.8 | |||||
3-Year Book Growth Rate | -60.2 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.68 | |||||
9-Day RSI | 41.58 | |||||
14-Day RSI | 41.57 | |||||
3-1 Month Momentum % | -9.8 | |||||
6-1 Month Momentum % | -11.96 | |||||
12-1 Month Momentum % | 5.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 16.08 | |||||
Quick Ratio | 14.92 | |||||
Cash Ratio | 11.04 | |||||
Days Inventory | 667.18 | |||||
Days Sales Outstanding | 111.35 | |||||
Days Payable | 3.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.4 | |||||
Shareholder Yield % | -3.11 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 70.43 | |||||
Operating Margin % | -347.99 | |||||
Net Margin % | -367.29 | |||||
EBITDA Margin % | -362.04 | |||||
FCF Margin % | -744.25 | |||||
OCF Margin % | -741.07 | |||||
ROE % | -122.82 | |||||
ROA % | -60.9 | |||||
ROIC % | -191.44 | |||||
3-Year ROIIC % | 1677.08 | |||||
ROC (Joel Greenblatt) % | -229.28 | |||||
ROCE % | -66.03 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 21.7 | |||||
EV-to-EBIT | -6.7 | |||||
EV-to-EBITDA | -6.7 | |||||
EV-to-Revenue | 24.25 | |||||
EV-to-Forward-Revenue | 18.07 | |||||
EV-to-FCF | -3.53 | |||||
Price-to-GF-Value | 1.76 | |||||
Price-to-Median-PS-Value | 1.87 | |||||
Earnings Yield (Greenblatt) % | -14.93 | |||||
FCF Yield % | -34.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Carna Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 291.386 | ||
| EPS (TTM) (円) | -55.94 | ||
| Beta | -0.09 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.33 | ||
| Volatility % | 73 | ||
| 14-Day RSI | 41.57 | ||
| 14-Day ATR (円) | 20.211133 | ||
| 20-Day SMA (円) | 336.7 | ||
| 12-1 Month Momentum % | 5.75 | ||
| 52-Week Range (円) | 200 - 512 | ||
| Shares Outstanding (Mil) | 19.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Carna Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Carna Biosciences Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| 100:1 Stock Split | 2013-12-26 | 698.00 (+2.80%) |
Show
Entries
Carna Biosciences Inc Frequently Asked Questions
What is Carna Biosciences Inc(TSE:4572)'s stock price today?
The current price of TSE:4572 is 円331.00. The 52 week high of TSE:4572 is 円512.00 and 52 week low is 円200.00.
When is next earnings date of Carna Biosciences Inc(TSE:4572)?
The next earnings date of Carna Biosciences Inc(TSE:4572) is .
Does Carna Biosciences Inc(TSE:4572) pay dividends? If so, how much?
Carna Biosciences Inc(TSE:4572) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Carna Biosciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers